Epithelial Ovarian Cancer Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 24
SKU : PH3371
240 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What are the segments covered in Epithelial Ovarian Cancer Drugs Market?
The segments are By Drug Type, By Distributional Channels, and By Region.
Who are the key players in Epithelial Ovarian Cancer Drugs Market?
Major players are AstraZeneca, Roche, Tesaro, Boehringer Ingelheim GmbH, Millennium Pharmaceuticals, Inc., Amgen, Inc., ImmunoGen, Inc., Pharmacyclics, Inc., Bayer AG, and Oasmia Pharmaceutical AB.
Related Reports
pharmaceuticalsUrological Cancer Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 25
Starting from
$4350
pharmaceuticalsEurope Ovarian Cancer Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 September 25
Starting from
$3750
pharmaceuticalsUrothelial Cancer Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 19
Starting from
$4350
pharmaceuticalsPolycystic Ovary Syndrome Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 03
Starting from
$4350
pharmaceuticalsMetastatic Breast Cancer Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 November 02
Starting from
$4350
pharmaceuticalsPhysiological Saline Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 November 02
Starting from
$4350